Consequently, GSK-3α knockdown significantly suppressed the cell viability of KRAS-WT lung cancer cell lines (H1993 and H1437), compared to KRAS-mutant lung cancer cell lines (H1734 and A549). The gene discussed is GSK3A; the disease is lung cancer.